Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and Risk Factors of Postoperative Crohn’s Disease Recurrence after an Ileocolonic Resection
Pauline Rivière(Université de Bordeaux), Yves Panís(Clinique Hartmann), Pär Myrelid(Linköping University), Steven R. Brown(University of Arizona), Gianluca Pellino(Universitat Autònoma de Barcelona), Gabriele Bislenghi(KU Leuven), Annemarie C. de Vries(Erasmus MC), Paulo Gustavo Kotze(International Organization for Migration), Marc Ferrante(Universitair Ziekenhuis Leuven), Christina Kapizioni(University General Hospital Attikon), Lieven Pouillon(Imelda Hospital), Bram Verstockt(Universitair Ziekenhuis Leuven), Míriam Mañosa(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Nurulamin M Noor(Cambridge School), Matthieu Allez(Inserm), Michele Carvello(Humanitas University), Willem A. Bemelman(Vrije Universiteit Amsterdam), Gabriele Dragoni(European Society for Sexual Medicine), Eugeni Domènech(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Edoardo Savarino(University of Padua), Mariangela Allocca(Vita-Salute San Raffaele University), Melissa Oliveira‐Cunha(University Hospitals Birmingham NHS Foundation Trust), Nassim Hammoudi, Naila Arebi
Cited by 25
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k